Esme Dijke


Organ transplantation saves the lives of patients with organ failure but their immune system will see the transplant as 'foreign' and try to reject it. To prevent rejection, transplant patients need lifelong medication that suppresses the immune system, but this causes harmful side effects. My research focuses on new strategies to assess the risk of potential rejection and to develop a therapy to prevent rejection using special immune cells called 'regulatory T cells'.